CD44 and gastric cancer: At first, the gain-of-function experiment revealed that BMX-ARHGAP overexpression increased expression of CD133, CD44, SOX2 and Nanog, and accelerated proliferation and invasion of GC cells and CD133, CD44 positive cells, indicating a promotive effect on GC stem cell properties.